New condition: Crohn’s disease

05 Jun New condition: Crohn’s disease

We are pleased to announce the addition of a new condition to our TreatGx website! Crohn’s disease is available for access to all TreatGx users. This algorithm provides medication treatment options for adults with mild, moderate and severe disease as well as for maintenance of remission after medical or surgical therapy. Medication treatment options and dosing are based on the most up to date guidelines from the American College of Gastroenterology[1], British Society of Gastroenterology[2], Canadian Association of Gastroenterology [3] and National Institute for Health and Care Excellence[4].  This algorithm also includes patient-specific dosing of medications based on age, weight, liver and kidney function, as well as pharmacogenetic information where relevant.

1. Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE: ACG Clinical Guideline: Management of Crohn’s Disease in Adults. The American journal of gastroenterology 2018, 113(4):481-517.
2. Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C et al: British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019, 68(Suppl 3):s1-s106.
3. Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U et al: Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease. J Can Assoc Gastroenterol 2019, 2(3):e1-e34.
4. National Institute for Health and Care Evidence: Crohn’s disease: management [NICE Guideline NG129]. 2019.